News & Events

Stay updated about latest news and where to meet us!

Unlock any part of the genome

Samplix Launches Xdrop™

02 September 2019. Today, Samplix is happy to announce the commercial launch of our Xdrop™ instrument for the targeted enrichment of long genomic regions from as little as 1 ng of DNA.

Scientists in the genomics field can now routinely capture up to 100 kb long genomic regions, based upon very limited target sequence information (100-200 bp of sequence). Using Xdrop™ technology together with long- or short-read sequencers makes it possible to sequence into regions that were previously inaccessible.

The types of genomic regions that are now unlocked by the Xdrop™ technology include:

Difficult to sequence regions Repetitive regions Integration sites from gene editing

machine illutration

Press Release

02 September 2019: Samplix Launches Xdrop™ – Providing PCR-free Target Enrichment of Single Molecules

Today, Samplix announced the commercial launch of its Xdrop™ sample preparation products for PCR-free target enrichment yet maintaining PCR-level specificity.

To read more, please see the full press release here:

02-09-2019. Samplix Press Release

Xdrop instrument RGB

Cancer Genomics 2019

Meet us at EMBL Cancer Genomics 2019, 4 -6 November in Heidelberg, Germany. 

Samplix is pleased to announce we will be demonstrating our recently launched Xdrop™ system at the EMBL Heidelberg Cancer Genomics 2019 conference in Heidelberg.

To see more and register for the event, please visit the conference website:

1200px EMBL logo svg

Genomic Medicine 2019 Nordic

Meet us at Genomic Medicine 2019 Nordic, 13 - 14 November in Copenhagen, DK. 

Samplix is pleased to announce we will be attending the Genomic Medicine 2019 Nordic conference 13 - 14 November at Kennedy Center at Rigshospitalet in Copenhagen.

To see more and register for the event, please visit the conference website:

Genomic medicine 2019 Nordic

Genomic Medicine 2019 Cambridge

Meet us at Genomic Medicine 2019 Cambridge, 20 - 21 November in Cambridge, UK. 

Samplix is pleased to announce we will be attending the Genomic Medicine 2019 Cambridge conference 20 - 21 November at Murray Edwards College in Cambridge, UK

To see more and register for the event, please visit the conference website:

Cambridge2

Samplix wins €1.9 million in Horizon 2020 SME program

Samplix wins €1.9 million in prestigious Horizon 2020 – SME Instrument program 

January 2019. Samplix is pleased to announce that the company has been selected by the European Commission among the winners of the prestigious Horizon 2020 – SME Instrument program, obtaining €1.9 million to mature its proprietary Xdrop™ technology. The selection process was highly competitive with more than 1.800 applicants and a success rate of only about 3%.

Samplix’ proprietary Xdrop™ technology comprises novel microfluidics, chemistry and bioinformatics in a simple work process that allows scientists and clinicians to partition millions of single molecules in droplets, thereby enabling both targeted enrichment and high-quality amplification of single molecules for sequencing analysis.

 The Xdrop™ technology is currently in beta test at leading research institutions world-wide.

 “We are excited to receive recognition and support by the European Commission for completion of our product development towards commercial launch of the Xdrop™ solution later this year” said CEO Lars Kongsbak.

To read more about Horizon 2020 SME awards, please viisit European Commission website:

horizon2020 eu commission logo 8 768x348